INR 802.8
(1.34%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 17.94 Billion | 15.06 Billion | 15.61 Billion | 10.56 Billion | 251.5 Million | 3.93 Billion |
Net Income | 9.39 Billion | 10.41 Billion | 23.64 Billion | 10.54 Billion | 1 Billion | 3.23 Billion |
Depreciation & Amortization | 6.56 Billion | 4.63 Billion | 2.72 Billion | 3 Billion | 1.59 Billion | 927.94 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 74.1 Million | - | - | - | - | - |
Change in working capital | 3.35 Billion | 2.42 Billion | -4.54 Billion | -1.28 Billion | -2.85 Billion | -7.49 Million |
Other non-cash items | 602.7 Million | -2.4 Billion | -6.21 Billion | -1.71 Billion | 511.08 Million | -224.65 Million |
Investing Cash Flow | -27.61 Billion | -19.54 Billion | -17.99 Billion | -4.98 Billion | -2.06 Billion | -4.5 Billion |
Investments in PPE | -18.87 Billion | -15.78 Billion | -9.39 Billion | -3.61 Billion | -1.88 Billion | -2.97 Billion |
Acquisitions | -3.73 Billion | -3.78 Billion | 103.8 Million | 2 Million | -2.8 Million | 831.18 Million |
Investment purchases | -6.78 Billion | -2.07 Billion | -7.23 Billion | -1.26 Billion | -1.54 Billion | -1.53 Billion |
Sales/Maturities of investments | 971.7 Million | 384.1 Million | 146.9 Million | -11.1 Million | 1.33 Billion | -822.44 Million |
Other Investing Activities | -3.25 Billion | 1.71 Billion | -1.61 Billion | -97.6 Million | 34.1 Million | -10 Thousand |
Financing Cash Flow | 9.15 Billion | 4.3 Billion | 1.66 Billion | -4.23 Billion | 1.94 Billion | 800.47 Million |
Debt repayment | -5.75 Billion | -6.18 Billion | -2.53 Billion | -3.17 Billion | -6.16 Billion | -1.03 Billion |
Dividends payments | -463.6 Million | -1.14 Billion | -1.83 Billion | -432.2 Million | - | - |
Common Stock Repurchased | -459.2 Million | - | -214.2 Million | - | - | - |
Common Stock Issuance | 13.79 Billion | - | 6.25 Billion | - | - | - |
Other Financing Activities | 2.91 Billion | 11.63 Billion | -3.6 Million | -622.6 Million | 8.11 Billion | 1.83 Billion |
Accounts receivables | -1.14 Billion | -2.25 Billion | 1.6 Billion | -3.64 Billion | -412.4 Million | 835.07 Million |
Accounts payables | 8.33 Billion | 3.33 Billion | 8.27 Billion | -2.13 Billion | -811.6 Million | -338.97 Million |
Inventory | 439.9 Million | -1.48 Billion | -10.26 Billion | 4.56 Billion | -4.14 Billion | -1.3 Billion |
Other working capital | -4.27 Billion | 2.82 Billion | -4.15 Billion | -65.1 Million | 2.5 Billion | 799.73 Million |
Cash at beginning of period | 907.9 Million | 919 Million | 1.63 Billion | 297 Million | 30.24 Million | 23.28 Million |
Cash at end of period | 394.2 Million | 747.8 Million | 919 Million | 1.63 Billion | 32.84 Million | 30.23 Million |
Capital Expenditure | -18.87 Billion | -15.78 Billion | -9.39 Billion | -3.61 Billion | -1.88 Billion | -2.97 Billion |
Effect of forex changes on cash | - | - | - | - | -127.65 Million | -218.42 Million |
Net cash flow / Change in cash | -513.7 Million | -171.2 Million | -719.4 Million | 1.34 Billion | 2.6 Million | 6.95 Million |
Free Cash Flow | -934.3 Million | -720.5 Million | 6.21 Billion | 6.95 Billion | -1.63 Billion | 953.01 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.76 Billion | 9.39 Billion | 2.16 Billion | 1.27 Billion | 4.84 Billion | 2.37 Billion |
Depreciation & Amortization | - | 6.56 Billion | - | 1.82 Billion | 1.76 Billion | 1.19 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 74.1 Million | - | - | - | - |
Change in working capital | - | 3.35 Billion | - | - | - | - |
Other non-cash items | -2.76 Billion | 602.7 Million | -2.16 Billion | -1.27 Billion | -4.84 Billion | -2.37 Billion |
Investing Cash Flow | - | -27.61 Billion | - | - | - | - |
Investments in PPE | - | -18.87 Billion | - | - | - | - |
Acquisitions | - | -3.73 Billion | - | - | - | - |
Investment purchases | - | -6.78 Billion | - | - | - | - |
Sales/Maturities of investments | - | 971.7 Million | - | - | - | - |
Other Investing Activities | - | -3.25 Billion | - | - | - | - |
Financing Cash Flow | - | 9.15 Billion | - | - | - | - |
Debt repayment | - | -5.75 Billion | - | - | - | - |
Dividends payments | - | -463.6 Million | - | - | - | - |
Common Stock Repurchased | - | -459.2 Million | - | - | - | - |
Common Stock Issuance | - | 13.79 Billion | - | - | - | - |
Other Financing Activities | - | 2.91 Billion | - | - | - | - |
Accounts receivables | - | -1.14 Billion | - | - | - | - |
Accounts payables | - | 8.33 Billion | - | - | - | - |
Inventory | - | 439.9 Million | - | - | - | - |
Other working capital | - | -4.27 Billion | - | - | - | - |
Cash at beginning of period | - | 907.9 Million | - | 599 Million | -4.24 Billion | 765 Million |
Cash at end of period | - | 394.2 Million | - | 1.27 Billion | 599 Million | 2.37 Billion |
Capital Expenditure | - | -18.87 Billion | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -513.7 Million | - | 674 Million | 4.84 Billion | 1.6 Billion |
Free Cash Flow | - | -934.3 Million | - | 1.27 Billion | 4.84 Billion | 2.37 Billion |
CMMHOSP
SANDHAR
BALPHARMA
AZMTF
RSAU
CANF